Michael Wegmann

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Frey, Lars Peter Lunding, Michael Wegmann
The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation. Cells 12 (18) (2023)
Felix Ritzmann, Lars Peter Lunding, Robert Bals, Michael Wegmann, Christoph Beisswenger
IL-17 Cytokines and Chronic Lung Diseases. Cells 11 (14) (2022)
Alexandra Schröder, Lars Peter Lunding, Ulrich M Zissler, Christina Vock, Sina Webering, Johanna C Ehlers, Zane Orinska, Adam Chaker, Carsten B Schmidt-Weber, Niklas J Lang, Herbert B Schiller, Marcus A Mall, Heinz Fehrenbach, Charles A Dinarello, Michael Wegmann
IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33. Allergy (2021)
Lars Peter Lunding, Damaris B Skouras, Christina Vock, Charles A Dinarello, Michael Wegmann
The NLRP3 inflammasome inhibitor, OLT1177® , ameliorates experimental allergic asthma in mice. Allergy (2021)
Lars Peter Lunding, Daniel Krause, Guido Stichtenoth, Cordula Stamme, Niklas Lauterbach, Jan Hegermann, Matthias Ochs, Björn Schuster, Radislav Sedlacek, Paul Saftig, Dominik Schwudke, Michael Wegmann, Markus Damme
LAMP3 deficiency affects surfactant homeostasis in mice. PLoS genetics 17 (6) (2021)
Sina Webering, Lars Peter Lunding, Christina Vock, Alexandra Schröder, Karoline I Gaede, Christian Herzmann, Heinz Fehrenbach, Michael Wegmann
The alpha-melanocyte-stimulating hormone acts as a local immune homeostasis factor in experimental allergic asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 49 (7) (2019)